70 related articles for article (PubMed ID: 18192882)
1. Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy.
Mambrini A; Bassi C; Pacetti P; Torri T; Iacono C; Ballardini M; Orlandi M; Guadagni S; Fiorentini G; Cantore M
Pancreas; 2008 Jan; 36(1):56-60. PubMed ID: 18192882
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience.
Mambrini A; Sanguinetti F; Pacetti P; Caudana R; Iacono C; Guglielmi A; Guadagni S; Del Freo A; Fiorentini G; Cantore M
In Vivo; 2006; 20(6A):751-5. PubMed ID: 17203761
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
7. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.
Papachristou E; Link KH; Schoenberg MH
Anticancer Res; 2003; 23(2A):831-4. PubMed ID: 12820308
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Aitini E; Marangolo M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):51-7. PubMed ID: 16767907
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.
Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Rabbi C; Marangolo M
J Chemother; 2004 Dec; 16(6):589-94. PubMed ID: 15700852
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
12. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
[TBL] [Abstract][Full Text] [Related]
13. The role of stable disease in objective response assessment and its impact on survival in advanced colorectal cancer: is "stable disease" a homogenous response category?
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
Neoplasma; 1999; 46(2):132-9. PubMed ID: 10466439
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
[TBL] [Abstract][Full Text] [Related]
15. [Regional chemotherapy in advanced pancreatic carcinoma].
Gansauge F; Link KH; Rilinger N; Kunz R; Beger HG
Med Klin (Munich); 1995 Sep; 90(9):501-5. PubMed ID: 7476726
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.
Eckel F; Lersch C; Lippl F; Assmann G; Schulte-Frohlinde E
J Exp Clin Cancer Res; 2000 Sep; 19(3):295-300. PubMed ID: 11144522
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
Beger HG; Link KH; Gansauge F
Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
[TBL] [Abstract][Full Text] [Related]
20. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
